As of Jun 28
| +0.15 / +0.19%|
The 15 analysts offering 12-month price forecasts for ResMed Inc have a median target of 72.54, with a high estimate of 96.50 and a low estimate of 50.00. The median estimate represents a -6.00% decrease from the last price of 77.17.
The current consensus among 19 polled investment analysts is to Buy stock in ResMed Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.